Pathfinder Cell Valuation
| PFND Stock | USD 0.0001 0.00 0.00% |
Pathfinder Cell seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pathfinder Cell Therapy from analyzing the company fundamentals such as EBITDA of (1.67 M), return on asset of -8.89, and Cash And Equivalents of 4 K as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Pathfinder Cell's price fluctuation is very steady at this time. Calculation of the real value of Pathfinder Cell Therapy is based on 3 months time horizon. Increasing Pathfinder Cell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pathfinder pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Pathfinder Cell Therapy. Since Pathfinder Cell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pathfinder Pink Sheet. However, Pathfinder Cell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The real value of Pathfinder Pink Sheet, also known as its intrinsic value, is the underlying worth of Pathfinder Cell Therapy Company, which is reflected in its stock price. It is based on Pathfinder Cell's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pathfinder Cell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pathfinder Cell Therapy helps investors to forecast how Pathfinder pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pathfinder Cell more accurately as focusing exclusively on Pathfinder Cell's fundamentals will not take into account other important factors: Pathfinder Cell Total Value Analysis
Pathfinder Cell Therapy is at this time estimated to have valuation of 7.41 M with market capitalization of 2 M, debt of 5.41 M, and cash on hands of 4 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pathfinder Cell fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.41 M | 2 M | 5.41 M | 4 K |
Pathfinder Cell Asset Utilization
One of the ways to look at asset utilization of Pathfinder is to check how much profit was generated for every dollar of assets it reports. Pathfinder Cell holds a negative application of assets of -8.89 pct., losing $0.0889 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Pathfinder Cell Therapy shows how discouraging it operates for each dollar spent on its assets.Pathfinder Cell Profitability Analysis
Net Loss for the year was (1.39 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pathfinder Cell's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pathfinder Cell and how it compares across the competition.
About Pathfinder Cell Valuation
The pink sheet valuation mechanism determines Pathfinder Cell's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pathfinder Cell. We calculate exposure to Pathfinder Cell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pathfinder Cell's related companies.Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. PATHFINDER CELL operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 1 people.
8 Steps to conduct Pathfinder Cell's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pathfinder Cell's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pathfinder Cell's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pathfinder Cell's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pathfinder Cell's revenue streams: Identify Pathfinder Cell's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pathfinder Cell's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pathfinder Cell's growth potential: Evaluate Pathfinder Cell's management, business model, and growth potential.
- Determine Pathfinder Cell's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pathfinder Cell's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pathfinder Cell Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pathfinder Cell does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 667.2 M | |
| Retained Earnings | -18.4 M |
Complementary Tools for Pathfinder Pink Sheet analysis
When running Pathfinder Cell's price analysis, check to measure Pathfinder Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pathfinder Cell is operating at the current time. Most of Pathfinder Cell's value examination focuses on studying past and present price action to predict the probability of Pathfinder Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pathfinder Cell's price. Additionally, you may evaluate how the addition of Pathfinder Cell to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |